Screener
Sutro Biopharma STRO Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's operating margin?
- Sutro Biopharma (STRO) reported operating margin of -120% in Q1 2026.
- How has Sutro Biopharma's operating margin changed year-over-year?
- Sutro Biopharma's operating margin increased by 68.2% year-over-year, from -376.9% to -120%.
- What is the long-term trend for Sutro Biopharma's operating margin?
- Over 4 years (2020 to 2025), Sutro Biopharma's operating margin has grown at a -1.8% compound annual growth rate (CAGR), from -166.3% to -154.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Sutro Biopharma's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude